Contact
Please use this form to send email to PR contact of this press release:
Oncoinvent Initiates Radspherin® Phase 2A Trial
TO:
Please use this form to send email to PR contact of this press release:
Oncoinvent Initiates Radspherin® Phase 2A Trial
TO: